Pluristem

Pluristem

Pluristem

A bio-therapeutics company developing a pipeline of products derived from human placenta - a non-controversial adult stem cell source.
Founded
2003
Raised
$51.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$15,000,000
Post-IPO equity - 2017
$30,000,000
Post-IPO equity - 2016
Innovative Medical Management
Team Size
1–10
Employees
Location
Headquarters
$15,000,000 Post-IPO equity
NoCamels

Pluristem Raises $15M, Can-Fite $5M

$3,300,000 Grant
Pharmaceutical Processing

Pluristem Secures $3.3M for R&D

NoCamels - Israeli Tech and Innovation News

Pluristem Gets $3.3M Grant From Government

$2,900,000 Grant
pluristem

Pluristem Therapeutics Inc. - June 17, 2015 (2)